Soligenix SNGX 2024 Rare Disease Treatment Investor Presentation

Soligenix is a late-stage biopharmaceutical company developing treatments for rare diseases and orphan indications across two segments: Specialized BioTherapeutics (oncology and inflammation) and Public Health Solutions (vaccines and therapeutics for infectious diseases and military applications).